Cosmos Health Inc. (COSM) - Total Assets
Based on the latest financial reports, Cosmos Health Inc. (COSM) holds total assets worth $65.48 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Cosmos Health Inc. for net asset value and shareholders' equity analysis.
Cosmos Health Inc. - Total Assets Trend (2010–2025)
This chart illustrates how Cosmos Health Inc.'s total assets have evolved over time, based on quarterly financial data.
Cosmos Health Inc. - Asset Composition Analysis
Current Asset Composition (December 2025)
Cosmos Health Inc.'s total assets of $65.48 Million consist of 58.6% current assets and 41.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 1.1% |
| Accounts Receivable | $19.63 Million | 30.0% |
| Inventory | $5.78 Million | 8.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $7.52 Million | 11.5% |
| Goodwill | $49.70K | 0.1% |
Asset Composition Trend (2010–2025)
This chart illustrates how Cosmos Health Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Cosmos Health Inc..
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cosmos Health Inc.'s current assets represent 58.6% of total assets in 2025, a decrease from 100.0% in 2010.
- Cash Position: Cash and equivalents constituted 1.1% of total assets in 2025, down from 100.0% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is accounts receivable at 30.0% of total assets.
Cosmos Health Inc. Competitors by Total Assets
Key competitors of Cosmos Health Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jointown Pharmaceutical Group Co Ltd
SHG:600998
|
China | CN¥112.28 Billion |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
|
China | CN¥21.18 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$46.10 Million |
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
Cosmos Health Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.00 | 1.05 | 1.33 |
| Quick Ratio | 0.85 | 0.87 | 1.22 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $116.41K | $1.26 Million | $10.42 Million |
Cosmos Health Inc. - Advanced Valuation Insights
This section examines the relationship between Cosmos Health Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.94 |
| Latest Market Cap to Assets Ratio | 0.20 |
| Asset Growth Rate (YoY) | 20.6% |
| Total Assets | $65.48 Million |
| Market Capitalization | $13.24 Million USD |
Valuation Analysis
Below Book Valuation: The market values Cosmos Health Inc.'s assets below their book value (0.20x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Cosmos Health Inc.'s assets grew by 20.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Cosmos Health Inc. (2010–2025)
The table below shows the annual total assets of Cosmos Health Inc. from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $65.48 Million | +20.56% |
| 2024-12-31 | $54.31 Million | -17.73% |
| 2023-12-31 | $66.01 Million | -2.97% |
| 2022-12-31 | $68.04 Million | +37.65% |
| 2021-12-31 | $49.43 Million | +12.74% |
| 2020-12-31 | $43.84 Million | +83.61% |
| 2019-12-31 | $23.88 Million | +15.39% |
| 2018-12-31 | $20.69 Million | +93.85% |
| 2017-12-31 | $10.68 Million | +242.33% |
| 2016-12-31 | $3.12 Million | +374.21% |
| 2015-12-31 | $657.62K | -90.91% |
| 2014-12-31 | $7.23 Million | +734.39% |
| 2013-12-31 | $867.05K | +2167525.00% |
| 2012-12-31 | $40.00 | -99.74% |
| 2011-12-31 | $15.24K | +3142.13% |
| 2010-12-31 | $470.00 | -- |
About Cosmos Health Inc.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It als… Read more